Catch Me, --Mechanisms of Tumor Immune Escape maker 李龙 商亮 孙健 宋春艳 郁舒靓 李丽丽 If You Can.

Slides:



Advertisements
Similar presentations
John A. Barrett Ph.D. Ziopharm Oncology, Boston MA 02129
Advertisements

Cell-Mediated Effector Responses Chapter 14
Cytokines receptors and biological functions. Cytokine Receptors  These are the receptors present on membrane of responsive target cells by which cytokines.
Diagnostic Immunology Topic: Immunological Tolerance Objectives: Define Immunological tolerance Define Immunological tolerance Discuss mechanism of tolerance.
Signaling to PROGRAM cell death (Apoptosis) Apoptosis is a cell mechanism used to eliminate cells that are unnecessary to or that contain mutations that.
Apoptosis By Dr Abiodun Mark .A.
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Host Responses to Viral Infection
T cell-mediated immunity Chapter 8
Tumor Immunology: Definitions: -Tumor (neoplasm): unchecked cellular growth. -Two types: 1-Benign: controlled tumor. 2-Malignant: uncontrolled tumor. -Malignant.
Cancer immunology and immunotherapy. First an aside  Oncogenes and tumor suppressor genes.  Definitions anyone?  Oncogene –  Tumor suppressor gene.
T lymphocytes Jianzhong Chen, Ph. D. Institute of Immunology, ZJU.
Apoptosis-related Diseases  Insufficient apoptosis  Excessive apoptosis  Coexistence of insufficient and excessive apoptosis.
Immune response and regulation 免疫应答 (immune response, Ir) Body receive stimulation from Ag , Specific lymphocytes recognize Ag , they activate, proliferate.
Pathophysiology of Type 1 Diabetes 1. Type 1 Diabetes Mellitus Characterized by absolute insulin deficiency Pathophysiology and etiology –Result of pancreatic.
Dental Microbiology #211 IMMUNOLOGY Lecture 5 Cellular Immunity: The functions of T cells.
Evgeniya Solodova Introduction: Regulatory cytokine transforming growth factor-β (TGF-β): - - is a secreted protein that exists in three isoforms.
Jianzhong Chen, Ph.D. Institute of Immunology, ZJU.
Lecture #10 Aims Describe T cell maturation and be able to differentiate naïve and effector T cells. Differentiate the development and functions of Th1.
The research progress of CD4+CD25+regulatory T cell The mechanism it participates in tumor immunity.
Tumor immunotherapy 张沛张书铭 张黎明 赵宸 赵世刚 Tumour Immunotherapy: questions Can immune stimulators combat cancer? Which forms of immunotherapy can be used?
By: Sara Ibrahim Tel. # Cancer and The Immune System.
Apoptosis in Cancer By: Karen Hutcherson Ryan Jenkins Angie Lam Jennie Zaborsky ISAT
Apoptosis Yasir Waheed. The cells of a multicellular organism are members of a highly organized community. The number of cells in this community is tightly.
Cell Suicide in Health and Disease
Lecture 11 Immunology Tumor immunology Dr: Dalia Galal.
Lecture 6 clinical immunology Cytokines
制片人 : 李晓颖 张媛媛 刘青 李芹 娄江华 田续江 刘波 张平 董铿 TumorImmunity.
HUMAN IMMUNODEFICIENCY VIRUS AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
Chapter 15.  Immunological tolerance is defined as unresponsiveness to an antigen that is induced by previous exposure to that antigen  Antigens that.
Cytokines To highlight the major cytokines that are mediators of: (i) natural immunity, (ii) adaptive immunity and (iii) hematopoesis.
CYTOKINE Hendy Kusnadi Pradipa Syarif. What Is A Cytokine? A small protein released by cells that has a specific effect on the interactions between cells,
Interferons Induction of synthesis Induction of antiviral activity Antiviral activities induced by interferons  and  Antiviral activities induced by.
NEGATIVE REGULATION OF THE IMMUNE SYSTEM
Cancer and the Immune System
Objectives Introduction Ags expressed by cancer cells
HOST DEFENCE AGAINST TUMORS:
Activation of T Lymphocytes
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Cytokines Non-antibody proteins acting as mediators between cells, termed: Monokines – mononuclear phagocytes Lymphokines – activated T cells, especially.
Targeting Immune Checkpoints in Esophageal Cancer: A High Mutational Load Tumor  Rajeev Dhupar, MD, Lauren Van Der Kraak, PhD, Arjun Pennathur, MD, Matthew.
M1 – Immunology EFFECTOR T CELL FUNCTIONS (Part I) March 27, 2009 Ronald B. Smeltz, Ph.D. Microbiology and Immunology
Chapter 43 The Immune System.
Cellular Immune response
GENERAL IMMUNOLOGY PHT 324
Thymocyte development summary
Zhang Lu Nat Cell Biol. 2016 Oct;18(10):
Immune system-Acquired/Adaptive immunity
Chemotherapy and Cancer Stem Cells
Avoiding Immune Detection
The function and mechanism of mast cell in anti-colon cancer immunity
T cell mediated immunity Part II
Death Signaling Pathways
Msc clinical immunology
Lymphoid system.
Humoral & Cell-mediated immunity
Differentiation and Functions of CD8+ Effector T Cells
Oncology Meets Immunology: The Cancer-Immunity Cycle
Figure 1 Immune mechanisms in liver homeostasis
Markers of cancer cell and lymphocytes in inflammatory infiltration around a tumour as potential markers of immunomodulatory treatment response. Markers.
Targeting Immune Checkpoints in Esophageal Cancer: A High Mutational Load Tumor  Rajeev Dhupar, MD, Lauren Van Der Kraak, PhD, Arjun Pennathur, MD, Matthew.
T –HELPER CELL AMMAR HADI
Figure 2 Altered innate immune functions after sepsis
Targets for immunotherapy of liver cancer
Mechanisms of immune escape in the tumor microenvironment.
Translated by Krishna Karamsetty
Combination extract inhibits immune responses in vivo.
SPECIFIC IMMUNE RESPONSE
Vaccines for Lung Cancer
Macrophages, Immunity, and Metabolic Disease
Presentation transcript:

Catch Me, --Mechanisms of Tumor Immune Escape maker 李龙 商亮 孙健 宋春艳 郁舒靓 李丽丽 If You Can

Terrorists Tumor cell T cellsoldiers

Items Camouflage Covering or blocking of tumor antigens Surface molecules change Resistance Fas/FasL TGF-β, IL-10 Surviving Immune selection Immunodeficiency

 Camouflage( 伪装 ) 1 Covering or blocking of tumor antigens on the surface of the tumor cell1 Covering or blocking of tumor antigens on the surface of the tumor cell Tumor cell Polysaccharide

2.Surface molecule of tumor cell change Lack of class I MHC

Mechanism The disorder of Fas expression and function A sFas C The unusual expression of FasL B

The disorder of Fas expression and function Absence of FasR’s expression 1 Absence of FasR’s apoptosis function 2 Esophageal carcinoma Liver carcinoma Gastric carcinoma phosphatase-1

Fas and Tumor Immunity Fas ligand expression by a variety of tumor cell lines and primary tumor isolates. Expression of Fas ligand by tumor cells has been suggested as a tumor escape mechanism, how tumor cells kill activated cytotoxic T cells and thus avoid an anti- tumor immune response.

O’Connell found colon carcinoma cells express functional FasL, thus he announced the model “Fas counterattack” in tumor immune escape. Fas counterattack

culturing the FasL tumor cells and Fas sensitive Jurkat T cells(or actived T cells) the latter apoptosise s tumor cell's FasL has the function of inducing apoptosis

normal

Tumor and activated T cells Two major pathways for CTL: Fas-mediated and perforrin-mediated Abnormal

Fas (CD95) belongs to the supperfamily members of tumor necrosis factor ( TNF) and nerve growth factor (NGF) receptor,which is expressed in many kinds of cells′surface. DEAD DOMAIN: about 70 amino acids in the plasma region

sFas’s mechanism There are some kinds of mRNA variations. Cells synthesize secretory protein(sFas) sFas prevents the apoptosis mediated by FasL and anti- Fas

sFas and leukemia In an experience, leukemia patients' sFas level is higher than normal level. Thus, the sfas level is stable and high in the leukemia against treatment.

FasL Fas TNF 活化的 CD8+ T 细胞 肿瘤细胞 Fas 死亡相关区 TNFR Inactive procaspase Actived caspase Dead tumor cell CTL 通过 FasL-Fas 作用诱导细胞凋亡

Secrete immune inhibitors (TGF-β,IL-10) Definition Tumor cells can secrete a variety of inhibitors to help their escape.They areTGF-β(Transforming Growth Factor β),IL-10 and VEGF(Vascular Endothelial Growth Factor) principally. This time we mainly introduce the principle of TGF-β. Almost TGF-β mRNA and TGF-β can be detected in all tumor cells. Tumor cells can secrete a variety of inhibitors to help their escape.They areTGF-β(Transforming Growth Factor β),IL-10 and VEGF(Vascular Endothelial Growth Factor) principally. This time we mainly introduce the principle of TGF-β. Almost TGF-β mRNA and TGF-β can be detected in all tumor cells.

TGF-β TGF-β1, TGF-β2,TGF-β3) The nucleotide sequences are highly homologous. I, II, III-type

Ⅰ. TGF-β can reduce the expression of MHC class II molecule in the tumor cell surface Chang discover C Ⅱ TA gene deficient mice’s immune cell surface defect MHC class II antigen. C II TA can control MHC class II antigen expression. Yi zhang’s research shows that TGF-β1 can significantly inhibit C Ⅱ TA gene’s transcription. TGF-β1 can inhibit C II TA gene transcription leading to reduce MHC class II antigen expression in tumor cells

Ⅱ. TGF-β acts on DC No or low expression of MHC Ⅱ molecules. 1

Allavena’s study IL-10 can reduce the expression of the surface molecules in DC such as MHC- Ⅱ,CD80,CD86 Inhibit the differentiation and maturation of DC

Ⅲ. TGF-β acts on T cell Inhibit the proliferation and differentiation of CTL effectively, influencing to the production of relative CTL Inhibit the proliferation and differentiation of CTL effectively, influencing to the production of relative CTL Promote Th2 cells to release IL-10 to inhibit the activation of macrophage and function of Th1 cells. Promote Th2 cells to release IL-10 to inhibit the activation of macrophage and function of Th1 cells.

Immune selection in the development of cancer: no two tumors are alike Initiation, proliferation diversification Microevolution, selection of immune resistance Immune escape and unchecked proliferation

The mechanisms of tumor cell escape is far complicated. As far as we are concerned, some mechanisms need being studied more, at the same time, a few of mechanisms have synergy (协同作用)。 The study of mechanism of tumor escape exerts some influences in tumor’s occurring and development, increasing immunity state, reversing tumor escape, etc.

Declaration Hand IN Hand Resisting the Carcinoma Altogether!!!